Company Filing History:
1 out of 1,287 
1 out of 371 
1 out of 10 Years Active: 2020
Title: Innovator in Oncology: Shinobu Tsuzuki
Introduction
Shinobu Tsuzuki, based in Aichi, Japan, is an accomplished inventor recognized for his contributions to the field of oncology. With a focus on developing new methods for diagnosing and treating serious blood cancers, Tsuzuki holds a notable patent that seeks to improve the accuracy of medical assessments for malignant lymphoma and leukemia.
Latest Patents
Tsuzuki's most significant innovation is encapsulated in his patent titled "Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia." This invention aims to provide a reliable method to determine whether an individual suffers from malignant lymphoma or leukemia. The process involves detecting specific genetic mutations, such as a fusion mutation of the DUX4 gene or overexpression of the same gene, as well as the fusion mutation of the MEF2D gene. Should any of these genetic indicators be present, it suggests the subject is likely suffering from or is at risk of these diseases. Additionally, his patent includes a pharmaceutical composition that contains a DUX4 inhibitor, designed for the treatment and prevention of malignant lymphoma or leukemia in affected patients.
Career Highlights
Shinobu Tsuzuki has made substantial strides in the academic and research sectors. He has been associated with prestigious institutions like the University of Tokyo and National University Corporation Nagoya University. Through his work, he has contributed to advancing medical science and enhancing patient outcomes in cancer treatment.
Collaborations
Throughout his professional journey, Tsuzuki has collaborated with esteemed colleagues, including Hiroyuki Mano and Toshihide Ueno. Their combined efforts have facilitated significant insights into the genetic underpinnings of blood cancers and the development of innovative treatment strategies.
Conclusion
In summary, Shinobu Tsuzuki stands out as a notable figure in the realm of cancer research and innovation. His patent not only reflects his dedication to improving diagnostic methods and treatment options for malignant lymphoma and leukemia but also underscores the importance of collaboration in advancing medical science. As he continues to develop groundbreaking solutions, his work promises to impact the lives of many individuals facing these challenging conditions.